Matches in Wikidata for { <http://www.wikidata.org/entity/Q38129997> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- Q38129997 description "article científic" @default.
- Q38129997 description "article scientifique" @default.
- Q38129997 description "articol științific" @default.
- Q38129997 description "articolo scientifico" @default.
- Q38129997 description "artigo científico" @default.
- Q38129997 description "artigo científico" @default.
- Q38129997 description "artigo científico" @default.
- Q38129997 description "artikel ilmiah" @default.
- Q38129997 description "artikull shkencor" @default.
- Q38129997 description "artículo científico" @default.
- Q38129997 description "artículu científicu espublizáu en 2013" @default.
- Q38129997 description "bilimsel makale" @default.
- Q38129997 description "scienca artikolo" @default.
- Q38129997 description "scientific article published on 16 August 2013" @default.
- Q38129997 description "scientific article published on 16 August 2013" @default.
- Q38129997 description "scientific article published on 16 August 2013" @default.
- Q38129997 description "vedecký článok" @default.
- Q38129997 description "vetenskaplig artikel" @default.
- Q38129997 description "videnskabelig artikel" @default.
- Q38129997 description "vitenskapelig artikkel" @default.
- Q38129997 description "vitskapeleg artikkel" @default.
- Q38129997 description "vědecký článek" @default.
- Q38129997 description "wetenschappelijk artikel" @default.
- Q38129997 description "wissenschaftlicher Artikel" @default.
- Q38129997 description "наукова стаття, опублікована в серпні 2013" @default.
- Q38129997 description "научная статья" @default.
- Q38129997 description "научни чланак" @default.
- Q38129997 description "מאמר מדעי" @default.
- Q38129997 description "مقالة علمية نشرت في 16 أغسطس 2013" @default.
- Q38129997 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38129997 name "Second-line treatment options in metastatic castration-resistant prostate cancer: a comparison of key trials with recently approved agents" @default.
- Q38129997 name "Second-line treatment options in metastatic castration-resistant prostate cancer: a comparison of key trials with recently approved agents" @default.
- Q38129997 name "Second-line treatment options in metastatic castration-resistant prostate cancer: a comparison of key trials with recently approved agents" @default.
- Q38129997 type Item @default.
- Q38129997 label "Second-line treatment options in metastatic castration-resistant prostate cancer: a comparison of key trials with recently approved agents" @default.
- Q38129997 label "Second-line treatment options in metastatic castration-resistant prostate cancer: a comparison of key trials with recently approved agents" @default.
- Q38129997 label "Second-line treatment options in metastatic castration-resistant prostate cancer: a comparison of key trials with recently approved agents" @default.
- Q38129997 prefLabel "Second-line treatment options in metastatic castration-resistant prostate cancer: a comparison of key trials with recently approved agents" @default.
- Q38129997 prefLabel "Second-line treatment options in metastatic castration-resistant prostate cancer: a comparison of key trials with recently approved agents" @default.
- Q38129997 prefLabel "Second-line treatment options in metastatic castration-resistant prostate cancer: a comparison of key trials with recently approved agents" @default.
- Q38129997 P1433 Q38129997-183AF471-F935-4085-B655-FB1EADC97B5C @default.
- Q38129997 P1476 Q38129997-E0E03718-B946-4571-A288-0F02B7EDD96C @default.
- Q38129997 P2093 Q38129997-267F379E-D0CA-4687-9FA6-6CCAF7E1D624 @default.
- Q38129997 P2093 Q38129997-7D987787-9A88-4C85-AC2A-3CCA1421A4F4 @default.
- Q38129997 P2093 Q38129997-A089AFF8-3BED-495B-8D8A-357DE691E5F7 @default.
- Q38129997 P2093 Q38129997-BB22A387-97ED-4932-B53F-77914DF4D837 @default.
- Q38129997 P304 Q38129997-64A944A6-1EAA-4033-927B-62AE1DD5B61F @default.
- Q38129997 P31 Q38129997-95DF4C51-BBCD-4DFB-9173-FB61EEB31836 @default.
- Q38129997 P356 Q38129997-EE8DC6FD-0845-4B12-9B61-72E76C1ADBD0 @default.
- Q38129997 P433 Q38129997-81652741-072C-4F16-A348-90994CD38383 @default.
- Q38129997 P478 Q38129997-D3F3904A-4CA6-4B2B-89BC-94A456114F5D @default.
- Q38129997 P50 Q38129997-BEFD17AF-CEF0-4D39-AA43-11E4E5121E04 @default.
- Q38129997 P577 Q38129997-2F48C945-B93B-4182-A3FC-12D09A57BAFC @default.
- Q38129997 P5875 Q38129997-79BF2A96-14CF-4516-BAE2-D89ED96DAB2B @default.
- Q38129997 P698 Q38129997-46AE19EE-5378-44A4-8E23-ABD51412CE43 @default.
- Q38129997 P8608 Q38129997-BFD99244-4B4E-430F-A49D-8B48654C7AE3 @default.
- Q38129997 P921 Q38129997-4E94D9EB-DC9C-4CE7-9AEA-D4273A32CB53 @default.
- Q38129997 P356 J.CTRV.2013.06.008 @default.
- Q38129997 P698 23958310 @default.
- Q38129997 P1433 Q1955762 @default.
- Q38129997 P1476 "Second-line treatment options in metastatic castration-resistant prostate cancer: a comparison of key trials with recently approved agents" @default.
- Q38129997 P2093 "Alison Birtle" @default.
- Q38129997 P2093 "Amit Bahl" @default.
- Q38129997 P2093 "Simon Chowdhury" @default.
- Q38129997 P2093 "Susan Masson" @default.
- Q38129997 P304 "170-177" @default.
- Q38129997 P31 Q13442814 @default.
- Q38129997 P356 "10.1016/J.CTRV.2013.06.008" @default.
- Q38129997 P433 "1" @default.
- Q38129997 P478 "40" @default.
- Q38129997 P50 Q43249916 @default.
- Q38129997 P577 "2013-08-16T00:00:00Z" @default.
- Q38129997 P5875 "255985023" @default.
- Q38129997 P698 "23958310" @default.
- Q38129997 P8608 "release_36confs6pnd5fooggp3e33mlyy" @default.
- Q38129997 P921 Q181257 @default.